Nafld fibrosis score blood test. The liver is the body’s filter. g. It combines routine blood tests (and sometimes age/height/weight) in a validated formula to classify your risk of advanced fibrosis (significant scarring that can progress to cirrhosis). 5. Clinical Significance Enhanced Liver Fibrosis (ELF) Score - The Enhanced Liver Fibrosis (ELF) score predicts progression to cirrhosis and liver-related events in patients with advanced fibrosis due to NASH. Feb 5, 2022 · What is a FibroScan? FibroScan is a specialized ultrasound machine to scan your liver to measure fibrosis (scarring) and steatosis (fat accumulation) in the liver. Well I had new lab results in my app monday and it looks like they verbally requested the lab check the advanced fibrosis blood test and my ELF is 7. It is indicated as a prognostic marker in conjunction with other laboratory findings and clinical assessments in patients with advanced fibrosis (F3 or F4) due to nonalcoholic Jun 16, 2025 · They include: AST-to-Platelet Ratio Index (APRI) score Fibrosis-4 (Fib-4) score Lipid profile This test measures blood fats, such as cholesterol and triglycerides. FIB-4 Calculator for NAFLD NB: This is only valid for non-alcoholic fatty liver disease (NAFLD) and is intended for use in conjunction with the NCL Abnormal LFT pathway. The fibrosis score is the amount of scarring. It provides an initial evaluation of potential liver scarring by using readily available information from routine blood tests. 0 (not <1. The higher scores are the ones you don't want. Mar 28, 2025 · What is the NAFLD fibrosis score? Healthcare professionals calculate the NAFLD fibrosis score using a person’s possible metabolic risk factors. The NAFLD (Non-Alcoholic Fatty Liver Disease) Fibrosis Score estimates amount of scarring in the liver based on several laboratory tests. 676 indicate a higher likelihood Jul 27, 2025 · While the NAFLD Fibrosis Score is a useful screening tool, it functions as an indicator rather than a definitive diagnostic test. It is most often discovered incidentally through elevated liver enzymes (ALT, AST) on routine blood work or fatty liver seen on ultrasound or other abdominal imaging. 4 days ago · Liver stiffness tests, such as vibration-controlled transient elastography (VCTE) like FibroScan, which helps estimate scarring In some cases, a liver biopsy if the diagnosis is unclear Fib-4 score (risk stratification) Doctors also use a Fib-4 score, a simple calculation based on age and common blood tests (like liver enzymes and platelets). 74. 2. There is a need for accurate biomarkers of fibrosis for population screening of alcohol-related and non-alcoholic fatty liver disease (ALD, NAFLD). It came up as 9. Non-alcoholic fatty liver disease (NAFLD) affects approximately 30% of adults in developed countries. The ELF Recommendation 7: Adults with NAFLD should undergo risk stratification to deter-mine the extent of their liver fibrosis (figures 1 and 2). 2. 67 warrants hepatology referral Indeterminate scores require Enhanced Liver Fibrosis (ELF) test or transient elastography Normal liver blood tests do not exclude NAFLD or significant fibrosis —ALT has only 50% sensitivity and 61% specificity for NASH, and ALT typically falls as fibrosis progresses. 6 Finally, the NAFLD fibrosis score includes age, BMI, blood glucose levels The aim of the present study was to prospectively evaluate and compare the diagnostic accuracy of several blood fibrosis tests including ELF test and the simple tests, NFS and FIB-4, as well as VCTE for detection of fibrosis stage among patients with NAFLD with or without NASH. . All Calculators CalculatorAboutReferences CalculatorAboutReferences NAFLD Fibrosis Score Reduce the need for liver biopsy by identifying patients with non-alcoholic fatty liver disease likely or unlikely to have advanced fibrosis Questions 1. 6 Finally, the NAFLD fibrosis score includes age, BMI, blood glucose levels Nov 21, 2025 · A year ago I had a ultrasound to measure KPA. several calculated scores, such as the NAFLD Fibrosis Score and FIB-4 Score, which are based on the results of routinely available blood tests and anthropometrics, have a high negative predictive value for advanced fibrosis/cirrhosis . Metabolic associated steatotic liver disease (MASLD) is the new nomenclature for non-alcoholic fatty liver disease (NAFLD). Many patients have normal liver enzymes and still have fatty liver. It is indicated as a prognostic marker in conjunction with other laboratory findings and clinical assessments in patients with advanced fibrosis (F3 or F4) due to nonalcoholic Stages of non-alcoholic fatty liver disease (NAFLD) NAFLD develops in 4 main stages. It is a non-invasive test that helps doctors assess the extent of liver damage without the need for a liver biopsy, which is more invasive and can be risky. LifeLabs® offers the Fibrosis-4 (FIB-4) Index and Enhanced Liver Fibrosis (ELF™) Score to screen for liver fibrosis in patients with non-alcoholic fatty liver disease (NAFLD). The enhanced liver fibrosis (ELF) blood test is the first-line investigation for assessing fibrosis in non-alcoholic fatty liver disease. and that I could actually die from this if there is fibrosis detected that could lead to cirrhosis. 51 or above – advanced fibrosis NAFLD (Non-Alcoholic Fatty Liver Disease) Fibrosis Score The NAFLD Fibrosis score estimates the amount of scarring in the liver based on several laboratory tests. If you have risk factors such as a family history of liver disease or heavy alcohol use, consider regular LFTs for early detection. 1 78 Tests Included Chronic Liver Disease With Fibrosis Score Package in Puri Also known as: Chronic Liver Disease With Fibrosis Score Package , ,Fatty Liver , NAFLD , Non alcoholic Fatty Liver Disease Fasting 12 hrs Reports within Report in 8 D For Male,Female Liver Function Tests (LFTs) are crucial blood tests that assess liver health by measuring enzymes and proteins. Feb 22, 2026 · Taking Action Before Symptoms Appear The best outcomes in fatty liver disease are achieved when the condition is identified and addressed before significant fibrosis or cirrhosis develops. 1 Long-Term Surveillance Considerations Also known as: Chronic Liver Disease With Fibrosis Score Package , ,Fatty Liver , NAFLD , Non alcoholic Fatty Liver Disease Fasting 12 hrs Reports within Report in 8 D For Male,Female Age: 5-99 Yrs 4 days ago · Learn how diet, exercise, and weight loss can reverse fatty liver, how long it takes, and when medical treatment may be needed. However, if any of these markers are unusually high or low, the FibroSure® algorithm may not be able to calculate one or more of the scores accurately. Jun 15, 2017 · The FIB-4 score has similar variables as the aspartate transferase to platelet ratio index, with the addition of age. Dec 28, 2021 · Fibrosis-4 (FIB-4) and the nonalcoholic fatty liver disease fibrosis score (NFS) are the 2 most popular noninvasive blood-based serum tests proposed for widespread fibrosis screening. It estimates the progression of scarring in the liver based on a few laboratory tests, can be used to predict the risk of end-stage liver disease and can evaluate the progression or stabilization of said liver disease. It can be used to help diagnose and monitor non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), hepatitis B and hepatitis C. 4. PLEASE NOTE: This pathway is a guide for the use of the ELF Score in the assessment of advanced liver fibrosis in patients with NAFLD. To compare blood tests of liver fibrosis specific for NAFLD: the FibroMeter NAFLD and the NAFLD fibrosis score (NFSA) with a non-specific test, APRI. The Enhanced Liver Fibrosis (ELF) Score is a noninvasive test that indicates whether a patient with NASH and advanced fibrosis has a higher or lower risk of disease progression to cirrhosis (for those with F3 fibrosis) or other liver-related clinical events (for those with F3 or F4 fibrosis) within 1 to 4 years. FibroScan can be used alone or with other tests (such as blood tests, imaging scans or biopsies) that also measure scarring or fatty change in your liver. Your FibroScan report may look like this: 6:37CC Overview of non-alcoholic fatty liver disease People with MASLD often have no noticeable symptoms, and it is often only detected during routine blood tests or unrelated abdominal imaging or liver biopsy. , transient The FibroSure® test is an algorithm-based test that provides scores for fibrosis, steatosis and NASH based on the results obtained for several blood markers. A Fibrosis Score estimates how much scarring (fibrosis) is present in your liver without a biopsy. Fatty change is when fat builds up in your liver cells. FIB-4 is simpler to calculate and performs better than other simple NITs in head-to-head comparisons, particularly in NAFLD. Clinicians use it to rule out low risk, flag high risk, and decide who needs imaging (e. While originally developed to detect liver fibrosis among patients with Hepatitis C and HIV It measures fibrosis (scarring) and steatosis (fatty change) in your liver. 67, and the APRI score at 0. It helps detect liver damage early—before symptoms appear. [30] For example, AST-to-platelets ratio index (APRI score) and several other scores, calculated from the results of blood tests, can detect the degree of liver fibrosis and predict the future formation of liver cancer. The NAFLDS and FIB-4 scores have similar accuracy for advanced fibrosis in patients aged >35 years. 49. It’s likely other blood tests will be done to rule out co-existing causes for fatty liver, including: Tests for chronic viral hepatitis, like hepatitis C Automatic calculation of such tests when liver blood tests are requested can potentially improve risk stratification in patients at risk of advanced fibrosis. com) which comprises 6 easily measured variables (age, body mass index, blood glucose, platelet count, albumin, and aspartate aminotransferase [AST] to alanine aminotransferase [ALT] ratio) [Chalasani et al, 2012]. It measures three markers (HA, PIIINP and TIMP-1) and uses an algorithm to provide a result that indicates whether they have advanced fibrosis of the liver: 10. Aug 5, 2025 · The Fibrosis-4 (FIB-4) score is a simple, non-invasive tool used to help assess liver health. This flow diagram offers a pragmatic approach to the diagnosis and monitoring of NAFLD in asymptomatic adult patients. Introduction: The SAFE (Steatosis-associated Fibrosis Estimator) score is a scoring system to categorize NAFLD patients by their risk of having significant liver fibrosis (stage 2 or higher) and long-term outcome. FIB-4 Index What it measures: fibrosis Who should take it: anyone concerned about their liver Where to get it: primary care provider, online calculator The FIB-4 Index is a blood-based diagnostic test that looks at underlying fibrosis that can be used as a measure to help determine NAFLD/NASH status. First-line testing should use either fibrosis-4 (FIB-4) or NAFLD Fibrosis Score (NFS) – see table 3 (level 2b, grade B). Symptoms and Diagnosis NAFLD is usually asymptomatic until advanced. We therefore aimed to describe the accuracy of FIB-4 and NFS to detect elevated liver stiffness as an indicator of hepatic fibrosis in low-prevalence populations. The extent of liver blood test abnormality is not necessarily a guide to clinical significance. Both medicines are meant for people with the more serious form of fatty liver disease (MASH), not simple MASLD without scarring. About our tests Metabolic dysfunction-associated steatotic liver disease Stay ahead of MASLD to prevent liver disease progression High rates of obesity, insulin resistance, and metabolic syndrome have led to an increase in metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD). These non-invasive blood tests help identify high-risk patients and reduce the need for complex procedures, ensuring early and effective management of liver health. The ELF score is not for use in the diagnosis of NASH, the staging of fibrosis, the serial monitoring of disease progression, or the monitoring of effects of therapeutic products. When I started researching it, I kept seeing things like fibrosis, cirrhosis and liver cancer Key Takeaways NASH is the inflammatory form of fatty liver disease that can progress to cirrhosis Up to 25% of people with simple fatty liver may develop NASH over time Silent progression means most people have no symptoms until advanced stages Weight loss of 7-10% can reduce liver inflammation and fibrosis NASH represents the dangerous progression of fatty liver disease, where accumulated fat Simple blood tests may help to determine the magnitude of the disease by assessing the degree of liver fibrosis. The NAFLD Fibrosis Score which uses 4 blood tests and information about your age, weight (BMI) and whether you have diabetes The Enhanced Liver Fibrosis (ELF) test which uses a combination of 3 blood tests. Mild yellow discoloration of the . Non-invasive methods include: Fatty liver disease (MASLD) often has no symptoms, which is why screening matters. A couple years ago I was diagnosed with Stage 3 fatty liver and it honestly scared the life out of me. [5][31] In some cases, it can cause symptoms related to liver dysfunction such as fatigue, malaise, and dull right-upper-quadrant abdominal discomfort. Originally used for weight loss, Wegovy is approved to treat MASH in adults with moderate to advanced liver fibrosis when used with diet and exercise. Nikhil Nanjappa explains how simple, non-invasive tests like blood work, FIB-4 score, and ultrasound can help detect risk early — before complications begin. Aug 23, 2022 · The NAFLD fibrosis score uses blood tests to assess the likelihood of liver scarring, helping doctors avoid more invasive procedures like biopsies. 24% with a prevalence in the Indian population ranging from 9% to 32%. Doctors recommend it when blood tests show abnormal liver enzymes, when there is a history of hepatitis, fatty liver, alcohol-related liver disease, obesity, diabetes, or long-term medication use. (Repeat testing every 2 years is suggested for patients with a low FIB-4 index. The Fib-4 score helps doctors decide: Who is at low risk for significant liver scarring Who needs more tests or follow-up care Mar 15, 2026 · How to Diagnose NAFLD Begin by confirming alcohol intake is below threshold (< 20 g/day for women, < 30 g/day for men), then obtain liver enzymes, metabolic labs, and abdominal ultrasound to detect steatosis, followed immediately by FIB-4 calculation to stratify fibrosis risk. Blood tests are necessary to gather this information, which includes platelet count, albumin levels, and levels of enzymes such as aspartate aminotransferase (AST) and alanine aminotransferase (ALT). 2, 3 The precise etiology of NAFLD is unknown; however The FIB-4 index is the preferred noninvasive initial test to assess the risk of NAFLD with liver fibrosis. A low Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease encircling a histological scale progressing from simple steatosis to steatohepatitis, and fibrosis. Patients with abnormal liver blood tests: should be considered for investigation with a liver (aetiology) screen irrespective of level and duration of abnormality. Scores above 0. 2 days ago · I was diagnosed with fatty liver in 2021 and i had a blood test done in december 2025 where my levels were 78 the blood test was then repeated 2 weeks ago and my levels were 95 should i be worried?? Liver problems such as fatty liver, hepatitis, and liver fibrosis can progress silently if not detected early. 3) to improve accuracy 4 Second-Line Fibrosis Assessment Quantitative tests: serum ELF or FibroScan/ARFI elastography 1 Important Note on Metabolic Risk 2 days ago · FIB-4 >2. However, I drank heavily two days before the test and current research said drinking close to a scan can skew the results making it We would like to show you a description here but the site won’t allow us. Liver Function Tests (LFTs) are crucial blood tests that assess liver health by measuring enzymes and proteins. Jun 16, 2025 · They include: AST-to-Platelet Ratio Index (APRI) score Fibrosis-4 (Fib-4) score Lipid profile This test measures blood fats, such as cholesterol and triglycerides. For whatever reason I started looking into Fatty Liver Disease and learned that NAFLD and AFLD are VERY different. Nov 17, 2022 · ELF score defines a three-marker fibrosis test (TIMP-1, PIIINP, HA) for assessing advanced fibrosis in NAFLD, guiding referrals and monitoring intervals. The main stages of NAFLD are: Simple fatty liver (steatosis) – a build-up of fat in the liver cells that may only be diagnosed during tests carried out for another reason Non-alcoholic steatohepatitis (NASH) – a more serious form of NAFLD, where the liver has become inflamed Fibrosis – where persistent Well I had new lab results in my app monday and it looks like they verbally requested the lab check the advanced fibrosis blood test and my ELF is 7. The Enhanced Liver Fibrosis (ELF™) blood test is a simple, accurate, non-invasive test that provides a simple, unitless numeric score that is generated via an algorithm for use in advanced liver fibrosis. It can tell you a grade of fattyness, steatosis ranging from 1-3, and a fibrosis score ranging from 1-4. If you have belly fat, prediabetes, type 2 Diabetes, high cholesterol, high blood pressure or metabolic syndrome, you may already be at risk for MASLD. The technology LIVERFASt (Fibronostics) is a blood test for detecting and staging the fibrosis (scarring), activity (inflammation) and steatosis (fat build-up) of the liver. The FAST score’s advantage comes from incorporating liver fat and stiffness data from the FibroScan rather than relying solely on blood markers. It combines six readily available clinical and laboratory variables: age, BMI, presence of diabetes, AST, ALT, platelet count, and Key Takeaways NASH is the inflammatory form of fatty liver disease that can progress to cirrhosis Up to 25% of people with simple fatty liver may develop NASH over time Silent progression means most people have no symptoms until advanced stages Weight loss of 7-10% can reduce liver inflammation and fibrosis NASH represents the dangerous progression of fatty liver disease, where accumulated fat We would like to show you a description here but the site won’t allow us. This NAFLD fibrosis score calculator stratifies the degree of fibrosis to the liver in nonalcoholic fatty liver disease patients by assigning a specific stage. 4 days ago · WEDNESDAY, March 19, 2026 (HealthDay News) — Fatty liver disease is when too much fat builds up in the liver. The Fibrosis-4 (FIB-4) Index for Liver Fibrosis is a non-invasive scoring system based on several laboratory tests that help to estimate the amount of scarring in the liver. nafldscore. 3. In this short video, Dr. 36 which is low risk for advanced fibrosis. Learn how doctors diagnose NAFLD—NAFL or NASH—using information from a medical history, a physical exam, blood tests, imaging tests, and liver biopsy. Diagnosis and the follow-up of liver fibrosis, steatosis, and inflammation Estimating hepatic fibrosis Assessing inflammation for metabolic diseases Assessing severity of nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease with steatosis (NAFLD) Assessing steatosis or fatty liver Reassuring patients with steatosis only, without fibrosis Managing patients with This NAFLD fibrosis score calculator identifies liver fibrosis in patients with non-alcoholic fatty liver disease (NAFLD). We compared the performance of the enhanced liver fibrosis (ELF) test to the fibrosis-4 index (FIB-4) and NAFLD fibrosis score (NFS), using transient elastography as the reference standard. NAFLD Fibrosis Score - The NAFLD fibrosis score is a simple noninvasive approach to identify patients that may have significant liver fibrosis and who therefore might benefit from additional studies such as elastography or liver biopsy. Other laboratory abnormalities that may be present include low-titre antinuclear antibody (ANA) in 20%–30% of patients and elevated ferritin levels. FibroScan is a simple, painless, and non-invasive test that helps measure liver stiffness and fat content—without the need for a biopsy. Age? NAFLD Fibrosis Score NAFLD Fibrosis Score is a non-invasive tool used to assess the severity of fibrosis in patients with non-alcoholic fatty liver disease. For instance, extremely elevated Body Mass Index (BMI) can impact the reliability of the score. The FIB-4 index is calculated using Testing for non-alcoholic fatty liver disease The term “Non-alcoholic fatty liver disease” (NAFLD) encompasses a spectrum of pathologic conditions, ranging from non-alcoholic fatty liver (NAFL) to steatohepatitis (NASH), fibrosis, and cirrhosis. A FibroScan is a simple, non-invasive test that measures liver stiffness and fat buildup. Fibrosis-4 (FIB-4) is a clinical marker used to evaluate the degree of liver fibrosis, particularly in patients with chronic liver diseases like hepatitis C and non-alcoholic fatty liver disease (NAFLD). When I started researching it, I kept seeing things like fibrosis, cirrhosis and liver cancer Fibrosis stage has been shown to be the strongest predictor of mortality associated with NAFLD. Advanced liver disease is preventable quite often. 7–10 ELF is included as a The FIB-4 score has similar variables as the aspartate transferase to platelet ratio index, with the addition of age. It is not a comprehensive pathway for the investigation of abnormal LFTs. Education Resource Non-invasive Assessment of Liver Fibrosis by Patricia R. It can help improve liver health and support weight loss. If you have risk factors for NAFLD — including obesity, type 2 diabetes, or metabolic syndrome — ask your doctor about liver health screening. The NAFLD Fibrosis Score (NFS) (available at www. This helps your doctor to understand your liver disease. 4 days ago · In some cases, a liver biopsy if the diagnosis is unclear Fib-4 score (risk stratification) Doctors also use a Fib-4 score, a simple calculation based on age and common blood tests (like liver enzymes and platelets). We would like to show you a description here but the site won’t allow us. Negative liver aetiology screen or if drinking excess alcohol, consider Fibroscan pathway. It’s likely other blood tests will be done to rule out co-existing causes for fatty liver, including: Tests for chronic viral hepatitis, like hepatitis C Jul 10, 2025 · What is the NAFLD Fibrosis Score? The NAFLD Fibrosis Score (NFS) is a widely used and validated clinical scoring system designed to identify patients with non-alcoholic fatty liver disease (NAFLD) who are at high risk for advanced liver fibrosis (stages F3-F4). It helps clean your blood, store energy and 3 days ago · The NAFLD fibrosis score (NFS) came in at 0. ) Patients in the high-risk groups with an indeterminate or high FIB-4 index should be considered for further testing with the ELF score. Please note: The use of the FIB-4 score is not validated where a patient is over 75 years of age. Its accuracy can be influenced by various factors, and it may not be as precise in all patient populations. Early screening. 3 days ago · First-Line Fibrosis Assessment Use FIB-4 or NAFLD Fibrosis Score 1 For patients >65 years old, use FIB-4 threshold <2. Your local guidance may differ. Your Understanding your FibroScan Results However for a certain number of these tests (BARD, FIB-4, NAFLD fibrosis score) much of the evidence is based on previously published and commonly agreed thresholds. 1 The global prevalence of NAFLD is 25. Early action. Your doctor may also order other tests to evaluate your liver, such as blood tests, other imaging scans, or biopsies. They aid in diagnosing conditions like hepatitis, cirrhosis, and fatty liver disease. Statistical analysis was conducted to evaluate the association of noninvasive liver fibrosis markers, Fibrosis-4 (FIB-4) index, nonalcoholic fatty liver disease Fibrosis score (NFS), and using transient elastography, both controlled attenuated parameter (CAP) and liver stiffness kilopascal (kPa) were measured at baseline and after 24 weeks in Very accurate. Slev, PhD View sample enhanced graphical report Test Details Scores are algorithmically calculated from values of blood biomarkers, platelet count, demographic information. Assessment of fibrosis severity is critical because it determines prognosis. Early screening can help prevent progression to liver inflammation, fibrosis, cirrhosis, and Fatty liver is common. vwzp epit trnvj zfflua agrku wsuho rskm xjleith vviv iuijkb